[Cl:1][C:2]1[CH:3]=[C:4]([CH:10]=[CH:11][C:12]=1[F:13])[O:5][CH2:6][C:7](Cl)=[O:8].[S:14]1[CH:18]=[CH:17][N:16]=[C:15]1[NH:19][S:20]([C:23]1[CH:24]=[C:25]2[C:29](=[CH:30][CH:31]=1)[CH2:28][NH:27][CH2:26]2)(=[O:22])=[O:21].CCN(CC)CC.C(Cl)Cl>CC#N>[S:14]1[CH:18]=[CH:17][N:16]=[C:15]1[NH:19][S:20]([C:23]1[CH:24]=[C:25]2[C:29](=[CH:30][CH:31]=1)[CH2:28][N:27]([C:7](=[O:8])[CH2:6][O:5][C:4]1[CH:10]=[CH:11][C:12]([F:13])=[C:2]([Cl:1])[CH:3]=1)[CH2:26]2)(=[O:22])=[O:21]2-(3-Chloro-4-fluorophenoxy)acetyl chloride (52 mg, 0.23 mmol) was added to a stirring solution of 2,3-Dihydro-1H-isoindole-5-sulfonic acid thiazol-2-ylamide (65 mg, 0.23 mmol), Et3N (64 μl, 0.46 mmol) and CH2Cl2 (500 μl), under N2. The reaction mixture was stirred at room temperature for 30 minutes. Product formation was observed by LC/MS (10-99% CH3CN). Purification by Gilson preparative HPLC (10-99% CH3CN) gave the desired amide. LC/MS (10-99% CH3CN), M/Z: M+1 obs=468.1; tR=2.95 min.
Loading…